The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.

A prospective study that investigates the impact of circadian rhythm disturbances due to daylight saving time transitions on migraine patients.The Primary aim is to investigate the impact of springtime DST (March 12 2023 at 2 AM on Sunday) on sleep metrics in patients with migraine headaches. Secondary aim is to examine the association between incidence of migraine headaches and sleep metrics with time transitions.Participants will be provided with a Withings non-wearable/contactless sleep tracker, which will be placed under the mattress for a period of 4 weeks (2 weeks before and 2 weeks after) during daylight saving time transition in March, 2023. Withings Health Mate app will be downloaded to the participant's smartphone to collect Sleep Data. Headache diaries will be provided to log the details of the migraines during the study period. Morningness - eveningness questionnaire (MEQ) will be used to categorize subjects on the chronotype spectrum.

Inclusion Criteria:Age 18 years and olderEpisodic migraine diagnosis based on ICHD 3 criteriaSubjects with smart phone who can download and use the Health Mate app available on iOS14 and higher and Android 8.0 and higher (Cannot be set up from a computer)Subjects that can commit to sleep on the same bed/mattress every night during the study periodSubjects that can commit not to use sleep aids (either prescription or over the counter sleep aids) or sedating medications (sedating anti-depressants, benzodiazepines, anti-histamines, anti-psychotics or gabapentinoids) that assist with sleep onset during the study period.Exclusion Criteria:Patients who do not meet ICHD-3 diagnostic criteria for migrainePatients with migraine diagnosis who are suspected or confirmed to have active medication overuse headaches during the study period.Patients who regularly use sleep aids (either prescription or over the counter sleep aids) or sedating medications (sedating anti-depressants, benzodiazepines, anti-histamines, anti-psychotics or gabapentinoids) to assist with sleep onset.Participants who are planning to initiate new treatment for sleep disorders during the study period.Subjects who participate in shift work.